Propranolol Dosing and Safety Guidelines

Acute Intravenous Management of Arrhythmias

Initial dose: 0.5 – 1 mg propranolol administered intravenously over 1 minute. The American Heart Association recommends this dose for stable narrow‑complex tachycardias unresponsive to adenosine or vagal maneuvers, and for ventricular‑rate control in atrial fibrillation/flutter. 1
Repeat dosing: Up to two additional 1 mg IV boluses may be given at 2‑minute intervals, not exceeding three total doses. 2
Maximum cumulative dose: 0.1 mg/kg total IV dose. 1
Monitoring requirements: Continuous ECG, frequent blood‑pressure checks, and auscultation for pulmonary rales or bronchospasm during and after administration. 4

Step‑down regimen: After an initial 0.5 – 1 mg IV dose, give 40 – 80 mg propranolol orally every 6‑8 hours, beginning 1–2 hours later. Intended for patients with unstable angina or NSTEMI. 4
Low‑risk alternative: In patients where early aggressive β‑blockade is a safety concern, start with 12.5 – 25 mg orally. 4
Target heart rate: Aim for a resting heart rate of 50 – 60 beats/min unless limited by side‑effects. 4
Critical contraindications in this setting: Low‑output state (e.g., oliguria), sinus tachycardia reflecting low stroke volume, sinus bradycardia < 50 bpm, systolic blood pressure < 90 mmHg, clinical signs of heart failure (rales, S3 gallop), or high risk for cardiogenic shock. 4

Usual dosing: 80 – 160 mg propranolol daily, divided into two doses. Evidence from hypertension‑focused studies supports this range. 6

Effective dosing range: 20 – 80 mg taken three or four times daily, yielding a total daily dose of 80 – 240 mg. Supported by clinical trials on migraine prevention. 8

Typical regimen: 40 – 80 mg three times daily to control tachycardia and tremor; propranolol also inhibits peripheral conversion of T₄ to the more active T₃. 8

Reactive airway disease or severe chronic obstructive pulmonary disease.
Decompensated heart failure.
Second‑ or third‑degree atrioventricular block or significant bradycardia without a pacemaker.
Cardiogenic shock.
Pre‑excited atrial fibrillation or flutter (e.g., Wolff‑Parkinson‑White syndrome).

In patients with mild wheezing or COPD, initiate a reduced oral dose (e.g., 12.5 mg) of a cardio‑selective β‑blocker rather than complete avoidance. 4

Interacting Drug	Effect on Propranolol Exposure
Rizatriptan or zolmitriptan	Increases concentrations by ~67‑75 % (rizatriptan) or ~56‑79 % (zolmitriptan).
Cimetidine	Increases propranolol AUC by ~46 %.
Cholestyramine or colestipol	Decreases propranolol concentrations by up to 50 %.

*These interaction data are derived from cardiovascular pharmacology studies. [1][2]

When hypoglycemia risk is present (e.g., in diabetic patients), propranolol should be taken with or after a meal, and doses should be withheld during periods of reduced oral intake or vomiting. 9